Macrophage Migration Inhibitory Factor in Vitiligo: Pathogenesis and Potential Therapeutic Aspects
Hassan Mohammed Ibrahim, Essam El-din Abd El-Aziz Nada, Soheir Abdel-Hamid Ali, Eisa Mohamed Hegazy, Mohammed H. Hassan
Asian Journal of Biochemistry, Genetics and Molecular Biology · pp. 8–24 · Published 29 Jun 2021
10.9734/ajbgmb/2021/v8i230189Abstract
Vitiligo is an acquired skin disorder that is characterized by a gradual loss of skin pigmentation when melanocytes, the skin's pigment-producing cellsis lost. Pathogenicmechanisms are not well understood. Genetic, abnormal biochemical pathways, autoimmune, melanocyte adhesion deficits and nervous system imbalances are among the pathogenic triggers. Vitiligo lesions have also been shown to have macrophage infiltration.Macrophagemigration inhibitory factor (MIF) is a lymphokine that concentrates macrophages at inflammatory sites and is involved in cell-mediated immunity.MIF enhances chemotaxis and macrophage infiltration and upregulates inflammatory responses by inducing the expression of proinflammatory mediators such as TNF-α, nitric oxide and prostaglandin E2.Therapyfor vitiligo includes corticosteroids, immunomodulatory agents, vitamin D nalogues, antioxidants, phototherapy, laser and surgical therapy.However, no single treatment for vitiligo produces consistently good results and treatment response is variable. Narrow-band ultraviolet (NB-UVB, 311–313nm) phototherapy is viewed as backbone of treatment. Systemic therapies such as systemic corticosteroids and methotrexate were previously used to treat vitiligo which was assumed to be auto-immune nature.Pathogenic mechanisms, role of MIF and various treatment guidelines are discussed in this review
References (33)
- 1 Guidelines for the management of vitiligo: the European Dermatology Forum consensus [DOI]
- 2 The Tautomerase Active Site of Macrophage Migration Inhibitory Factor Is a Potential Target for Discovery of Novel Anti-inflammatory Agents [DOI]
- 3 Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy [DOI]
- 4 Vitiligo: An Update on Pathophysiology and Treatment Options [DOI]
- 5 Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo [DOI]
- 6 Afamelanotide and Narrowband UV-B Phototherapy for the Treatment of Vitiligo [DOI]
- 7 Treatment of vitiligo vulgaris with narrow‐band UVB and oral Polypodium leucotomos extract: a randomized double‐blind placebo‐controlled study [DOI]
- 8 The role of vitamin D in melanogenesis with an emphasis on vitiligo [DOI]
- 9 Activated NLR family pyrin domain containing 3 (NLRP3) inflammasome in keratinocytes promotes cutaneous T-cell response in patients with vitiligo [DOI]
- 10 Vitiligo and Other Diseases: Coexistence or True Association? [DOI]
- 11 Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites [DOI]
- 12 Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF‐M [DOI]
- 13 Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids [DOI]
- 14 Inhibition of MIF Bioactivity by Rational Design of Pharmacological Inhibitors of MIF Tautomerase Activity [DOI]
- 15 Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis. [DOI]
- 16 Prevalence of Vitiligo and Associated Comorbidities in Korea [DOI]
- 17 Depigmentation therapies for normal skin in vitiligo universalis [DOI]
- 18 Inflammasome activation and vitiligo/nonsegmental vitiligo progression [DOI]
- 19 Levamisole in Dermatology [DOI]
- 20 Low-Energy Helium-Neon Laser Induces Locomotion of the Immature Melanoblasts and Promotes Melanogenesis of the More Differentiated Melanoblasts: Recapitulation of Vitiligo Repigmentation In Vitro [DOI]
- 21 Topical treatment in vitiligo and the potential uses of new drug delivery systems [DOI]
- 22 Efficacy of methotrexate as anti‑inflammatory and anti‑proliferative drug in dermatology: Three case reports [DOI]
- 23 Treatment of vitiligo with a chimeric monoclonal antibody to CD20: a pilot study [DOI]
- 24 Minocycline Impact on Redox Homeostasis of Normal Human Melanocytes HEMn-LP Exposed to UVA Radiation and Hydrogen Peroxide [DOI]
- 25 Regulatory Role of C5a on Macrophage Migration Inhibitory Factor Release from Neutrophils [DOI]
- 26 Macrophage Migration Inhibitory Factor Secretion Is Induced by Ionizing Radiation and Oxidative Stress in Cancer Cells [DOI]
- 27 Migration inhibitory factor (MIF) released by macrophages upon recognition of immune complexes is critical to inflammation in Arthus reaction [DOI]
- 28 Effectiveness of a combined 308-nm excimer lamp and topical mid-potent steroid treatment for facial vitiligo: a preliminary, randomized double-blinded controlled study [DOI]
- 29 MIF production by dendritic cells is differentially regulated by Toll-like receptors and increased during rheumatoid arthritis [DOI]
- 30 Comparative study between excimer light and topical antioxidant versus excimer light alone for treatment of vitiligo [DOI]
- 31 Detection of auto antibodies and transplantation of cultured autologous melanocytes for the treatment of vitiligo [DOI]
- 32 Segmental Vitiligo Treated by the Combination of Epidermal Grafting and Systemic Corticosteroids [DOI]
- 33 Vitiligo Lesions Improved after Oral Cyclosporine in a Patient with Vitiligo and Atopic Dermatitis
Cited by 8
Gustavo Camacho Meza, Guadalupe Avalos Navarro, Ulises De La Cruz Mosso · International Journal of Molecular Medicine · 2025
Rosalyn M. Fey, Rebecca A. Nichols, Thuy T. Tran · Cancers · 2024
Shiva Tushir, Monu Yadav, Anil Kumar · Drug Repurposing for Emerging Infectious Diseases and Cancer · 2023
Showing 3 of 8 known citations — external sources report more than can currently be individually listed.
Related research
- Use of Therapy Diary as a Method for Monitoring and Improving Adherence to Metformin Therapy in Diabetic Patients — shares topic coverage
- Factors Affecting the Use of Probiotics during Antibiotic Therapy — shares topic coverage
- Sensory Garden for Occupational Therapy and Improving Quality of Life — shares topic coverage
- Etiology and Bacterial Antimicrobial Susceptibility of Endometritis in Camels (Camelus dromedarius) — shares topic coverage
- The Efficacy of Quality of Life Therapy on Mental Health in the Families of Patients with Chronic Psychiatric Disorders — shares topic coverage
Article metrics
Real usage data collected on this platform.
61
Page views
0
PDF downloads
23
Outbound clicks
8
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.